Skip to main content

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Inmune Bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Inmune Bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Inmune Bio, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Clark Ronnie DuaneDirector–Sep 23, 20261
Sapirstein JamesDirector–Sep 17, 20261
Juda ScottDirector86,404Jul 7, 20263
Lowdell Mark WilliamChief Scientific Officer1,518,017Jul 7, 20263
Moss David JChief Executive Officer1,294,883Jul 7, 20263
Allen MarciaDirector–Dec 2, 20252
Schroeder Timothy jDirector82,187IndirectDec 2, 20252
Ganjei James KellyDirector17,793Dec 2, 20252
Ellspermann Cory RandallCFO–Dec 2, 20252
Tesi Raymond JosephPresident and CEO1,554,106Dec 9, 20240
Baracchini Edgardo JrDirector–May 16, 20240
Xencor Inc10% Owner1,885,533Sep 8, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 30, 2024 (view filing)Sep 30Same dayMoss David JChief Financial OfficerPPurchase+10.0K$5.29+$52.9K+0.8%1.29M after
Sep 16, 2024 (view filing)8:48 PM ETSep 124 daysTesi Raymond JosephPresident and CEOPPurchase+15.4K$6.38+$98.0K+1.0%1.55M after
Sep 16, 2024 (view filing)8:48 PM ETSep 124 daysTesi Raymond JosephPresident and CEOPPurchase+15.4K$0.125+$1.92K–15.4K afterDerivative
Sep 16, 2024 (view filing)8:47 PM ETSep 124 daysMoss David JChief Financial OfficerPPurchase+7.69K$6.38+$49.0K+0.6%1.28M after
Sep 16, 2024 (view filing)8:47 PM ETSep 124 daysMoss David JChief Financial OfficerPPurchase+7.69K$0.125+$961.25–7.69K afterDerivative
Jun 26, 2024 (view filing)Jun 251 dayJuda ScottDirectorPPurchase+5.00K$7.27+$36.4K+7.5%71.6K after
Apr 24, 2024 (view filing)2:10 PM ETApr 195 daysMoss David JCFO, Treasurer & SecretaryPPurchase+18.0K$8.32+$150.0K+1.4%1.27M afterAmended
Apr 24, 2024 (view filing)2:10 PM ETApr 195 daysMoss David JCFO, Treasurer & SecretaryPPurchase+18.0K$0.125+$2.25K–18.0K afterAmendedDerivative
Apr 24, 2024 (view filing)2:08 PM ETApr 195 daysTesi Raymond JosephPresident and CEOPPurchase+18.0K$8.32+$150.0K+1.2%1.54M afterAmended
Apr 24, 2024 (view filing)2:08 PM ETApr 195 daysTesi Raymond JosephPresident and CEOPPurchase+18.0K$0.125+$2.25K–18.0K afterAmendedDerivative
Apr 24, 2024 (view filing)2:08 PM ETApr 195 daysLowdell Mark WilliamChief Scientific OfficerPPurchase+14.4K$8.32+$120.0K+1.0%1.51M afterAmended
Apr 24, 2024 (view filing)2:08 PM ETApr 195 daysLowdell Mark WilliamChief Scientific OfficerPPurchase+14.4K$0.125+$1.80K–14.4K afterAmendedDerivative
Apr 24, 2024 (view filing)2:07 PM ETApr 195 daysJuda ScottDirectorPPurchase+29.6K$8.32+$246.3K+80.0%66.6K afterAmended
Apr 24, 2024 (view filing)2:07 PM ETApr 195 daysJuda ScottDirectorPPurchase+29.6K$0.125+$3.70K–29.6K afterAmendedDerivative
Nov 13, 2023 (view filing)Nov 103 daysJuda ScottDirectorPPurchase+7.00K$6.95+$48.6K+23.3%37.0K after
Jul 14, 2023 (view filing)Jul 122 daysSchroeder Timothy jDirectorSSale−10.0K$11.01−$110.1K−10.8%82.2K after10b5-1
Mar 20, 2023 (view filing)Mar 173 daysMoss David JCFO, Treasurer & SecretaryPPurchase+2.50K$6.43+$16.1K+0.2%1.25M after
May 31, 2022 (view filing)May 265 daysTesi Raymond JosephPresident and CEOPPurchase+6.30K$6.41+$40.4K+0.4%1.52M after
May 31, 2022 (view filing)May 26-275 daysMoss David JCFO, Treasurer & SecretaryPPurchase+10.7K$6.42+$68.6K+0.9%1.25M after2 lots
Nov 17, 2021 (view filing)Nov 17Same dayJuda ScottDirectorPPurchase+2.50K$13.55+$33.9K+9.1%30.0K after
Nov 4, 2021 (view filing)Nov 31 dayLowdell Mark WilliamChief Scientific OfficerSSale−701$20.00−$14.0K0.0%1.47M after
Nov 4, 2021 (view filing)Nov 31 dayMoss David JCFO, Treasurer & SecretarySSale−1.02K$20.00−$20.5K−0.1%1.22M after
Nov 4, 2021 (view filing)Nov 31 dayTesi Raymond JosephPresident and CEOSSale−3.63K$20.00−$72.5K−0.2%1.49M after
Oct 29, 2021 (view filing)Oct 272 daysTesi Raymond JosephPresident and CEOSSale−6.52K$20.00−$130.3K−0.4%1.49M after
Oct 29, 2021 (view filing)Oct 272 daysLowdell Mark WilliamChief Scientific OfficerSSale−2.36K$20.00−$47.1K−0.2%1.47M after
Oct 29, 2021 (view filing)Oct 272 daysMoss David JCFO, Treasurer & SecretarySSale−2.08K$20.00−$41.6K−0.2%1.22M after
Oct 26, 2021 (view filing)Oct 224 daysTesi Raymond JosephPresident and CEOSSale−23.6K$20.00−$472.3K−1.5%1.50M after
Oct 26, 2021 (view filing)Oct 224 daysLowdell Mark WilliamChief Scientific OfficerSSale−400$20.00−$8.00K0.0%1.48M after
Oct 26, 2021 (view filing)Oct 22-254 daysMoss David JCFO, Treasurer & SecretarySSale−1.16K$20.00−$23.1K−0.1%1.22M after2 lots
Jul 14, 2021 (view filing)Jul 131 daySchroeder Timothy jDirectorSSale−14.5K$27.63−$400.1K−13.6%92.2K after
Jul 12, 2021 (view filing)Jul 93 daysSchroeder Timothy jDirectorSSale−30.0K$23.21−$696.3K−22.0%106.7K after
Jul 9, 2021 (view filing)Jul 7-82 daysLowdell Mark WilliamChief Scientific OfficerSSale−30.0K$20.16−$604.7K−2.0%1.48M after2 lots
Jul 9, 2021 (view filing)Jul 7-82 daysMoss David JCFO, Treasurer & SecretarySSale−25.0K$20.06−$501.6K−2.0%1.20M after2 lots
Jul 9, 2021 (view filing)Jul 7-82 daysTesi Raymond JosephPresident and CEOSSale−30.0K$20.07−$602.1K−1.9%1.51M after2 lots